Skip to content

The effect of Pelargonium graveolens Capsules on the severity of menstrual pain in female students.

"Investigating the Effects of Pelargonium graveolens Soft Capsules on the Severity of Primary Dysmenorrhea in Students of Islamic Azad University, Shahrekord: A Randomized Clinical Trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250803066739N1
Enrollment
72
Registered
2025-09-19
Start date
2025-09-06
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhea. Pain and other conditions associated with female genital organs and menstrual cycle

Interventions

Intervention group: The intervention group received 50 mg soft capsules of fragrant geranium essential oil standardized based on 15 to 22 mg of citronellol (manufactured by Barich Essential Oils) twic

Sponsors

Shahre-kord University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 25 Years

Inclusion criteria

Inclusion criteria: Having moderate to severe primary dysmenorrhea (score equal to or greater than 4 on the visual analog scale), being single, being students between 18 and 25 years old (the age group with the highest incidence of PD and the most severe clinical manifestations), having a regular menstrual cycle of 21 to 35 days, and willingness to participate in the study.

Exclusion criteria

Exclusion criteria: Medical students at Shahrekord Azad University with primary dysmenorrhea, a history of regular exercise, consumption of any herbal tea, any known physical disease, any known psychological disease, consumption of any medication (chemical or herbal and hormonal), addiction to cigarettes, alcohol and similar things, allergy to medicinal herbs.

Design outcomes

Primary

MeasureTime frame
Percentage of students with severe primary dysmenorrhea in the two groups. Timepoint: Before the start of the intervention, one month after the end of the intervention, and two months after the end of the intervention. Method of measurement: Visual Analogue Pain Scale.;Quality of primary dysmenorrhea in two groups. Timepoint: Before the start of the intervention, one month after the end of the intervention, and two months after the end of the intervention. Method of measurement: McGill Pain Questionnaire Short Form.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFaranak Safdari

Shahre-kord University of Medical Sciences

faranaksafdari@gmail.com+98 38 3334 1216

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026